lupin annual report 2020-21

Lupin rises on getting USFDA’s approval for Rufinamide Tablets

Lupin is currently trading at Rs. 688.15, up by 0.60 points or 0.09% from its previous closing of Rs. 687.55 on the BSE. The scrip opened at Rs.…

19 Aug 2022 7:45 AM

Lupin is currently trading at Rs. 612.10, up by 2.20 points or 0.36% from its previous closing of Rs. 609.90 on the…

9 Jun 2022 10:02 AM

Lupin is currently trading at Rs. 923.50, up by 20.05 points or 2.22% from its previous closing of Rs. 903.45 on the…

25 Jan 2022 9:41 AM